tm logo

Monitor this mark

View On USPTO

OWP
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 06 Dec 2023

Last Applicant/ Owned by

OWP Pharmaceuticals, Inc.

Suite 400

Naperville

IL

60563

Serial Number

86506959 filed on 19th Jan 2015

Registration Number

5233027 registered on 27th Jun 2017

in the Principal Register

Correspondent Address

Kenneth S. McLaughlin, Jr.

Kenneth S. McLaughlin, Jr.

1 E. BENTON ST.

SUITE 301

AURORA,IL 60505

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

OWP

Pharmaceutical preparations for the treatment of epilepsy

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of epilepsy

First Use Date in General

25th May 2016

First Use Date in Commerce

25th May 2016

Mark Details

Serial Number

No 86506959

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 441/606

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.07.01 -

Globes with outlines of continents

02.11.15 -

Imprints of hands; fingerprints

Legal History

Show more

Status DateAction Taken
06th Dec 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06th Dec 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06th Dec 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08th Jun 2023TEAS SECTION 8 & 15 RECEIVED
27th Jun 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08th Jan 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08th Jan 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08th Jan 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
27th Jun 2017REGISTERED-PRINCIPAL REGISTER
25th May 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED